糖尿病黄斑水肿临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 糖尿病黄斑水肿（国际通用名 diabetic macular edema）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。
正在招募的糖尿病黄斑水肿新药试验
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
II 期招募中美国中国Czechia德国NCT06962839Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
I 期招募中美国NCT05802329Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema
III 期招募中中国NCT07515079Gene Therapy for DME
I 期 / II 期招募中中国NCT06492876Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
不适用招募中EgyptNCT07295704Aflibercept in Recurrent or Persistent CNV
不适用招募中AustriaNCT02669953Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab
不适用招募中CroatiaNCT07520045Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
不适用招募中SwedenNCT06549023Patients With Type 2 Diabetes
不适用招募中中国台湾NCT07245082Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
早期 I 期招募中中国NCT07362927High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
IV 期招募中美国NCT06662994A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
III 期招募中美国NCT07734844
糖尿病黄斑水肿试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。